Kazam Joshua A 4
4 · Allogene Therapeutics, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Kazam Joshua A
Director
Transactions
- Award
Restricted Stock Unit
2025-06-18+94,500→ 94,500 total→ Common Stock (94,500 underlying)
Footnotes (1)
- [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.